Fingerprint
Dive into the research topics of 'Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically